Hikal Limited (NSE:HIKAL)
India · Delayed Price · Currency is INR 214.33
-10.41 (-4.63%)
Jul 22, 2026, 3:30 PM IST
Hikal Market Cap
Hikal has a market cap or net worth of 27.75 billion as of July 22, 2026. Its market cap has decreased by -34.48% in one year.
Market Cap
27.75B
Enterprise Value
34.45B
Revenue
17.13B
Ranking
n/a
PE Ratio
n/a
Stock Price
214.33
ChartMarket Cap Chart
Since May 6, 2002, Hikal's market cap has increased from 1.36B to 27.75B, an increase of 1,944.55%. That is a compound annual growth rate of 13.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 27.75B | -0.82% |
| Dec 31, 2025 | 27.98B | -41.82% |
| Dec 31, 2024 | 48.09B | 28.50% |
| Dec 29, 2023 | 37.42B | -26.02% |
| Dec 30, 2022 | 50.58B | -22.11% |
| Dec 31, 2021 | 64.94B | 219.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aarti Pharmalabs | 64.18B |
| Innova Captab | 55.09B |
| Orchid Pharma | 52.82B |
| RPG Life Sciences | 47.30B |
| Solara Active Pharma Sciences | 27.50B |
| Indoco Remedies | 22.84B |
| Beta Drugs | 22.50B |
| Ind-Swift Laboratories | 20.07B |